Citation Impact
Citing Papers
Calorie Restriction Promotes Mammalian Cell Survival by Inducing the SIRT1 Deacetylase
2004 StandoutScience
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
2003 StandoutNobel
X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C
2011 StandoutNobel
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas
1999
Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors
1997 Nature
Requirement of Cysteine-rich Repeats of the Fas Receptor for Binding by the Fas Ligand
1997
Matters of life and death: programmed cell death at Cold Spring Harbor
1998
Molecular Pathogenesis of Cholestasis
1998
Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo
1999 Standout
Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene
2003 StandoutNobel
Membrane-bound Fas ligand only is essential for Fas-induced apoptosis
2009 Nature
The Tn Antigen—Structural Simplicity and Biological Complexity
2011
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
1999 Standout
Nonalcoholic Fatty Liver Disease
2002 Standout
Apoptosis by Death Factor
1997 Standout
Immunology and immunotherapy approaches for prostate cancer
2007
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
1998 StandoutNatureNobel
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
Reactive Oxygen Intermediates Are Involved in the Induction of CD95 Ligand mRNA Expression by Cytostatic Drugs in Hepatoma Cells
1997
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
The Hallmarks of Cancer
2000 Standout
Tumor-specific killer cells in paraneoplastic cerebellar degeneration
1998
The biochemistry of apoptosis
2000 StandoutNature
Apoptosis and cancer: the genesis of a research field
2009
Management of Hepatocellular Carcinoma *
2005 Standout
Natural selection of tumor variants in the generation of “tumor escape” phenotypes
2002
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
2007 StandoutNature
TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL
1997
Regulation of Ferroptotic Cancer Cell Death by GPX4
2014 Standout
CD95(APO-1/Fas)-Mediated Apoptosis: Live and Let Die
1998
The biology of the P-glycoproteins
1995
The C. elegans Protein EGL-1 Is Required for Programmed Cell Death and Interacts with the Bcl-2–like Protein CED-9
1998 StandoutNobel
TWEAK, a New Secreted Ligand in the Tumor Necrosis Factor Family That Weakly Induces Apoptosis
1997
Immunity, Inflammation, and Cancer
2010 Standout
Osteoclast differentiation and activation
2003 StandoutNature
Premalignant lesions of hepatocellular carcinoma: pathologic viewpoint
2000
Apoptosis in the aging process
2000
Identification and Assessment of Adherence-Enhancing Interventions in Studies Assessing Medication Adherence Through Electronically Compiled Drug Dosing Histories: A Systematic Literature Review and Meta-Analysis
2013
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
2004 StandoutNature
Death and anti-death: tumour resistance to apoptosis
2002 Standout
CD95(APO-1/Fas)-Mediated Apoptosis in Normal and Malignant Liver, Colon, and Hematopoietic Cells
1998
Sialylation of the Fas Death Receptor by ST6Gal-I Provides Protection against Fas-mediated Apoptosis in Colon Carcinoma Cells
2011
A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
1998 StandoutNature
Osteoporosis after solid organ and bone marrow transplantation
2003
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
Errors of homeostasis and deregulated apoptosis
1997
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
2001 StandoutNature
Impact of aging and life‐long calorie restriction on expression of apoptosis‐related genes in male F344 rat liver
2002
The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy
1997
Inhibition of death receptor signals by cellular FLIP
1997 StandoutNature
Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non‐cirrhotic and cirrhotic chronic viral hepatitis
2001
Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts
2002 Standout
Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance
1999
Impaired apoptosis, extended duration of immune responses, and a lupus-like autoimmune disease in IEX-1-transgenic mice
2002 StandoutNobel
Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis
2015
The Bcl-2 Protein Family: Arbiters of Cell Survival
1998 StandoutScience
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Immune Escape of Tumors in Vivo by Expression of Cellular Flice-Inhibitory Protein
1999
Cell Activation and Apoptosis by Bacterial Lipoproteins Through Toll-like Receptor-2
1999 StandoutScience
Proteasome regulation of activation-induced T cell death
1997 StandoutNobel
Density Variant Glycan Microarray for Evaluating Cross-Linking of Mucin-like Glycoconjugates by Lectins
2012 StandoutNobel
Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors
1997 StandoutScience
Regulation of the Proinflammatory Effects of Fas Ligand (CD95L)
1998 Science
Cellular and molecular mechanisms in cancer immune escape: a comprehensive review
2013
Conversion of Membrane-bound Fas(CD95) Ligand to Its Soluble Form Is Associated with Downregulation of Its Proapoptotic Activity and Loss of Liver Toxicity
1998
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs
1998
Death Receptors: Signaling and Modulation
1998 StandoutScience
Requirement for the CD95 Receptor-Ligand Pathway in c-Myc-Induced Apoptosis
1997 Science
Regulation of apoptosis by the circadian clock through NF-κB signaling
2011 StandoutNobel
Fas Preassociation Required for Apoptosis Signaling and Dominant Inhibition by Pathogenic Mutations
2000 StandoutScienceNobel
Interventions for enhancing medication adherence
2014 Standout
Involvement of TRAIL and its receptors in viral hepatitis
2002
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.
1995
Cyclosporin A-Sensitive Transcription Factor Egr-3 Regulates Fas Ligand Expression
1998
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Live-Cell Labeling of Specific Protein Glycoforms by Proximity-Enhanced Bioorthogonal Ligation
2015 StandoutNobel
FLIP Prevents Apoptosis Induced by Death Receptors But Not by Perforin/Granzyme B, Chemotherapeutic Drugs, and Gamma Irradiation
1998
A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels
1998 StandoutNobel
MATURE T LYMPHOCYTE APOPTOSIS—Immune Regulation in a Dynamic and Unpredictable Antigenic Environment
1999
The Receptor for the Cytotoxic Ligand TRAIL
1997 StandoutScience
Cell Survival Promoted by the Ras-MAPK Signaling Pathway by Transcription-Dependent and -Independent Mechanisms
1999 StandoutScience
Interleukin-3-Induced Phosphorylation of BAD Through the Protein Kinase Akt
1997 StandoutScience
Molecular Pathogenesis of Cholestasis
2004
THE UBIQUITIN SYSTEM
1998 StandoutNobel
Caspases: Enemies Within
1998 StandoutScience
Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
2004 StandoutScience
Works of Gerd Otto being referenced
Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma
2015
Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1 /Fas) Mediated apoptosis
1998
Inhibition by cyclosporin A of Adenosine triphosphate-dependent transport from the hepatocyte into bile
1993
Expression of MUC1, Thomsen-Friedenreich antigen, Tn, sialosyl-Tn, and α2,6-linked sialic acid in hepatocellular carcinomas and preneoplastic hepatocellular lesions
1999
Loss of CD95 expression is linked to most but not all p53 mutants in European hepatocellular carcinoma
2001
Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes
1990
Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia
1997
Impact of a Pharmaceutical Care Program on Liver Transplant Patients’ Compliance With Immunosuppressive Medication: A Prospective, Randomized, Controlled Trial Using Electronic Monitoring
2009
Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study
2001
Lymphocyte apoptosis induced by CD95 (APO–1/Fas) ligand–expressing tumor cells — A mechanism of immune evasion?
1996
Survival and Recurrence After Liver Transplantation Versus Liver Resection for Hepatocellular Carcinoma
1998